Viscient Bio Revenue and Competitors
Estimated Revenue & Valuation
- Viscient Bio's estimated annual revenue is currently $2.5M per year.
- Viscient Bio's estimated revenue per employee is $155,000
Employee Data
- Viscient Bio has 16 Employees.
- Viscient Bio grew their employee count by 0% last year.
Viscient Bio's People
| Name | Title | Email/Phone |
|---|
Viscient Bio Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Viscient Bio?
We are focused on utilizing 3D culture technology to develop drugs across a range of therapeutic areas. Founded by a combination of former Organovo and Ardea Biosciences scientists and entrepreneurs, Viscient is initially conducting discovery and development work in non-alcoholic fatty liver disease (“NAFLDâ€) and non-alcoholic steatohepatitis (“NASHâ€). Utilizing newly available three dimensional biology technologies, we explore biology in a previously unavailable context, leading to a better understanding of disease and an improved opportunity to impact patients.
keywords:N/A
N/A
Total Funding
16
Number of Employees
$2.5M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in San Diego
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.4M | 16 | N/A | N/A |
#2 | $1.4M | 16 | N/A | N/A |
#3 | $1.4M | 16 | N/A | N/A |
#4 | $1.2M | 16 | -48% | $22.9M |
#5 | $1.4M | 16 | 7% | N/A |